Long-lived cytotoxic T lymphocyte memory in mucosal tissues after mucosal but not systemic immunization by unknown
Long-lived  Cytotoxic T  Lymphocyte Memory in Mucosal 
Tissues After Mucosal but Not Systemic  Immunization 
By W. Scott Gallichan and Kenneth L. 1Kosenthal 
From the Molecular Virology & Immunology Programme, Department of Pathology and Department of 
Biology, McAlaster University Health Sciences Centre, Hamilton, Ontario, Canada 
Summary 
The induction and maintenance of long-term CTL memory at mucosal surfaces may be a crit- 
ical component of protection against mucosal pathogens and is one goal towards development 
of effective mucosal vaccines.  In these studies we have functionally evaluated short and long- 
term CTL memory in systemic and respiratory or genital-associated lymphoid tissues following 
mucosal or systemic routes of immunization. Our results indicate that shortly after immunizing 
mice with a recombinant adenovirus vector expressing glycoprotein ~  (gB)  of herpes simplex 
virus (AdgB8), gB-specific CTL memory responses were observed in systemic and mucosal im- 
mune compartments regardless of the route of inoculation. In contrast, several months after im- 
munization,  anamnestic  CTL responses compartmentalized exclusively to mucosal or systemic 
lymphoid tissues after mucosal or systemic immunization, respectively. Furthermore,  the com- 
partmentalized  CTL  memory  responses  in  mucosal  tissues  were  functionally  observed  for 
longer than 1.5 yr after intranasal immunization, and CTL precursor frequencies one year after 
immunization  were  comparable  to those  seen  shortly after immunization.  Therefore,  to our 
knowledge, this is the first functional demonstration that the maintenance of anti-viral memory 
CTL in mucosal tissues is dependent on the route of immunization and the time of assessment. 
These results have important implications for our understanding of the development,  mainte- 
nance, and compartmentalization of functional T  cell memory and the development and evalu- 
ation of vaccines for mucosal pathogens, such as HSV and HIV. 
M 
emory is  a  hallmark  of both  humoral  and  T  cell- 
mediated immune responses and is typified by a more 
rapid and intense  immune response  on re-exposure  to the 
same or closely related antigen. Indeed, a desirable property 
of vaccines is the ability to generate long-term immunolog- 
ical  memory  capable  of preventing  infection  or  limiting 
disease.  Our current understanding ofT cell memory stems 
from studies  of systemic immune responses,  however little 
is known concerning the induction and maintenance ofT cell 
memory  responses  in  mucosal  tissues.  Numerous  patho- 
gens,  including  respiratory,  gastrointestinal  and  sexually 
transmitted  agents,  such as HSV and human immunodefi- 
ciency virus  (HIV),  initiate  infection  at  mucosal  surfaces. 
Since  the  mucosal  immune  system  is  somewhat  separate 
and distinct from systemic immunity (1-3), a better under- 
standing of specific immunologic T  cell memory in mucosal 
tissues  should  contribute  to  the  development  of effective 
mucosal  vaccines  and  improved  control  of infections  at 
these sites. 
Mucosal surfaces  are largely protected  by secretory IgA 
as well as transudated IgG antibodies  (4).  The induction of 
B  cells in mucosal tissues following antigen exposure or in- 
fection results  in  the  migration  of B  lymphocytes to mu- 
cosal tissues in the common mucosal immune system, thus 
ensuring  the  maintenance  of secretory  immunity  at  mu- 
cosal  surfaces  (1-3).  T  cell-mediated  immunity  is  also  a 
critical  component  of protection  against  mucosal  patho- 
gens. In addition to the detection of cell-mediated cytotox- 
icity in mucosa-associated tissues  (5,  6), the passive transfer 
of CTL is associated with the clearance of virus at mucosal 
surfaces  and  may  reduce  virus-related  pathology  (7-12). 
Furthermore,  as with B cells,  mucosally derived T  cells mi- 
grate to mucosal tissues and this homing is even more pro- 
nounced dunng re-exposure to the same pathogen (2,  12). 
The  maintenance  of T  cell memory to  viruses  may be 
the result of long-lived antigen-specific lymphocytes (13-15). 
Alternatively,  T  cell memory may be maintained  by con- 
stant snmulation as a result of antigen persistence  (16,  17), 
i&otypic networks  (18)  or cross-reactions with other anti- 
gens  (19).  Of interest  to us,  and an often ignored issue,  is 
that  the  development  of immune  responses  within  the 
unique  environments  of secondary  lymphoid  tissues  (20, 
21)  and the  homing of effector and memory lymphocytes 
to the tissues in which antigen exposure originally occurred 
(12,  22,  23)  may restrict  the maintenance  and observation 
of T  cell  memory to  distinct  immune  compartments.  In- 
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intranasally (i.n.)  1 against HSV,  we  observed a  decline in 
the levels of splenic CTL such that one year after immuni- 
zation we were unable to detect any anti-HSV CTL in the 
spleen.  Interestingly, these  mice  were  protected  from  an 
intranasal challenge with HSV-2  (24).  We  suspected that 
the lack of detectable splenic CTL at this time was a reflec- 
tion of the recruitment, retention, and recirculation of spe- 
cific CTL within the common mucosal immune system af- 
ter intranasal immunization. In support of this theory was 
the  concurrent observation that although systemically im- 
munized animals displayed short-term protection from mu- 
cosal HSV-2 challenge, protection was not long-lived de- 
spite  the  fact  that  CTL  specific  for  HSV-2  were  readily 
detectable in the spleen (24). 
Therefore, in this study we have examined the develop- 
ment  and  the  long-term maintenance of CTL  memory 
within the distinct immune compartments of the mucosal 
and systemic immune systems after antigen exposure in ei- 
ther  compartment.  To  induce  immunity to  HSV,  mice 
were  immunized with  a  recombinant adenovlrus vector 
expressing  the  immunodominant CTL  antigen  of HSV, 
glycoprotein B  (AdgB8). The CTL immune responses that 
developed were evaluated in the spleen and mucosal tissues 
of the respiratory and genital tracts. 
Cytotoxic T  lymphocyte memory has been functionally 
observed as an enhanced secondary CTL response in vitro 
(25-27)  and in vivo (13,  28-33) after re-exposure to anti- 
gen. We functionally examined HSV-specific memory CTL 
in the spleen after restimulation and expansion with antigen 
in vitro. CTL memory within the mucosal immune com- 
partments  of AdgB8  immunized mice  was  examined by 
detecting the rapid recall response after re-exposure to ant> 
gen in vivo. Our results indicate that the funcnonal presenta- 
tion  of short-term  CTL  memory  is  independent of the 
route of antigen exposure, whereas long-term CTL mem- 
ory compartmentalizes over time and is dependent on the 
route of immunization. 
Materials  and Methods 
Animals and Cell Cultures.  Inbred female C57BL/6 (H-2  b) mice 
(purchased  from Charles  River Canada,  St.  Constant, Quebec, 
Canada) were used for these studies. 293 and 293-N2S cells were 
grown in ot-MEM (GIBCO Laboratories,  Burlington, Canada), 
supplemented with 10% FCS (GIBCO), and 1% peniclllin-strep- 
tomycin and L-glutamine (GIBCO). MC57  (H-2  b)  and SVBalb 
(H-2  d) fibroblasts served as targets in the CTL assays. 
Virus Strains and Inoculations.  The construction of replication- 
competent recombinant adenovlrus vectors,  AdgB8  and AdE3-, 
is reported elsewhere  (33, 34). In brief, AdgB8 contains the gly- 
coprotein B  (gB) gene from HSV-1  coupled to the  SV40 pro- 
moter and inserted into the E3 region of human adenovlrus type 
1Abbreviations used in this paper: CI, confidence interval; h.f.p., hand foot 
pad; HSV-2, HSV type 2; ILN, lliac lymph nodes; l.n., mtranasally;  wag, 
intravaglnally; LU, lytac units; MLN, medlastmal lymph nodes; MOI, 
mulnpliclty  of refection. 
5.  AdE3- contains a deletion in the E3  region and served  as a 
control. The recombinant adeimviruses were grown in 293-N2S 
cells, purified twice on CsC1 gradients,  and titered on 293  cells 
(35). The vaccima vector expressing gB ofHSV-1 (VacgB11) was 
kindly provided by B. Moss  (NIH, Bethesda,  MD) and its con- 
struction is reported elsewhere  (36). HSV type 2 (HSV-2)  strain 
333  was propagated  and virus  tltres  were  determined on Vero 
cells. Each  mouse was  immunized with a  total  of 108  PFU of 
AdgB8 or AdE3- in the given volumes ofPBS pH 7.4. Mice im- 
munized i.n. were  anaesthetized  with Halothane, inverted, and 
10-20 }xl of virus in PBS was introduced into the nares by means 
ofa microplpet (24). 1.p. and hind foot pad (h.f.p.) immunizations 
were performed by inoculation of virus in 0.2  ml and 50 txl of 
PBS, respectively.  Mice were challenged  antravaginally (ivag) or 
1.n. with 107 PFU of HSV-2 in 10 or 20 D1 of PBS, respectively. 
Intravaginally challenged mice were  first inoculated subcutane- 
ously with  2  mg of progestin/mouse (Depo-Provera,  Upjohn, 
Don Mills, Ontario) 5 d before challenge,  and then anesthetized 
using Halothane,  swabbed with  a  cotton applicator,  placed  on 
their backs and infected for 1 h while under anesthetic. 
CTL Assays.  Spleen and lymph node effector cells were pre- 
pared by teasing the tissues through a stainless steel grid.  Splenic 
CTL were examined following secondary  in vitro stimulation as 
follows; isolated spleen cells were incubated for 6 d with gamma- 
irradiated  (5,000 rad), AdgB8-infected, syngeneic MC57 cells, at 
an effector/stimulator ratio of 1:166 in RPMI 1640 medium with 
10% FCS,  50  IxM 2-mercaptoethanol, 1% L-glutamane, penicil- 
hn, and streptomycin. After stimulation splenic effector cells were 
incubated with uninfected and HSV-2-mfected (nmltiplicity of 
infection [1] MOI =  10, 6-h infection period)  syngeneic (MC57) 
and allogenelc  (SVBalb) targets at effector to target ratios of 80:1, 
40:1, 20:1, and 10:1 in a 6-h S  lCr_release assay. Inhibition of cy- 
totoxiclty was determined by adding 100 Ixl of monoclonal anti- 
body 145-2C11  (antl-CD3) to wells containing effector cells 1 h 
before addition of target cells at the 40:1 ratio. Data are expressed 
as percent-specific lysis =  100  X  [(experimental  cpm -  sponta- 
neous  cpm)/(maximum  release  cpm  -  spontaneous  release 
cpm)].  Cytotoxlc T lymphocytes from lymph nodes draining the 
site of infection were examined in a primary CTL assay by the 
protocol of Pfizenmaier et  al.  (37) with  modifications (38). In 
brief,  in the primary CTL assay lymphocytes from lymph nodes 
draining the site of infection were harvested  from mice 2 or 3 d 
post  HSV-2  challenge  and incubated for  3  d  (without antigen 
stimulation) in RPMI 1640 medium (supplemented as above). In 
vitro incubation (without antigen) has been shown to be neces- 
sary in the herpes system for CTL to become fully cytolync (37). 
After incubation, the lymph node effectors were incubated with 
targets  in a 6 h  SlCr release assay as described  above.  VacgB11 
(MOI =  10, 16-h infection period)  as well as HSV-2 infected (as 
above) and uninfected fibroblasts served as targets. 
Determination  of  CTL  Precursor Frequencies  and  Lytic  Units. 
For determining the CTL precursor frequencies  of HSV-2-spe- 
ClfiC splenocytes  limiting dilution analysis  was  performed.  In 
brief, splenocytes were isolated by Ficol gradient and txtrated into 
round bottom, 96-well plates (NUNC, P, oskllde, Denmark) with 
12  replicates  at  each  dilution.  Feeders  (irradiated  splenocytes: 
2,000  rids) were isolated by Flcol gradient and added at 2 ×  105 
mononuclear cells per well.  Stimulators  were  irradiated  (2,000 
rads) with HSV-2-mfected splenocytes  set at 2  ×  10S/well.  5 d 
after  incubation, the  contents of each  well was transferred  to  a 
corresponding well in V-bottomed NUNC plates and 5,000 51Cr 
labeled and HSV-2- or VacgB-infected syngenelc fibroblasts were 
added to each well.  Plates were pulse spun up to 1,500 rpm and 
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fined as those wells whose SlCr release exceeded the mean spon- 
taneous release from control cultures, containing feeder cells but 
no responder cells, by at least three standard deviations. 
The  assay  used  to  determine  CTL  precursor  frequencies  of 
HSV-2-specific lymphocytes from the  draining lymph nodes of 
immunized mice was  similar to  that  reported by Nugent et  al. 
(31,  33).  This method involved expansion of CTL in the pres- 
ence of exogenous cytokines but m the absence of added antigen, 
and results an analysis of effector CTL expanded from CTLp ex- 
clusively activated in vivo after HSV-2  challenge. Lymphocytes 
from lliac lymph nodes of mace infected ivag with HSV-2 were 
titrated into round-bottom, 96-well plates, in 100 txl of supple- 
mented RPMI with 16 replicates for each lymphocyte concentra- 
tion. Feeders (irradiated splenocytes, 2,000 rads)  were isolated by 
Ficol gradient and added at 2  ×  105 mononuclear cells per well m 
100  p~l of 5 U  of rlL-2 (Genzyme, Cambridge, MA),  10%  (vol/ 
vol)  Rat  T-Stlm  (Collaborative Biomedical Research  Products, 
Cambridge, MA), and 50 mM co-methyl mannosade (Sigma). 5 d 
after incubation cultures were assessed as above for CTL precur- 
sor frequencies. 
The  lytlc  activity  of CTL  in  the  draining lymph  nodes  of 
HSV-2-mfected  tissues  was  estimated  by  determining the  lytac 
units (LU).  One LU is  defined as  the  number of mononuclear 
cells required to obtain 10% specific lysls of 5,000 infected targets. 
The 10% level oflysis was chosen to accommodate the low levels 
of killing experienced by certain experimental groups. We have 
expressed  the  lytic  activity of the  mononuclear cells  recovered 
from the draining lymph nodes as the number of lytic units per 
107  cells.  In short,  mononuclear cells  were  harvested  from  the 
lymph nodes draining the sites of HSV-2 infection and incubated 
for 3  d  (37)  in RPMI  1640 medium with  10% fetal calf serum, 
50 btM 2-mercaptoethanol, 1% L-glutamine, penicillin, and strep- 
tomycin. The lymph node effectors were then plated in twofold 
serial dilutions in 96-well V-bottomed plates (NUNC, P,  oskllde, 
Denmark) with 12 rephcates  at each dilution. 5,000 HSV-2-1nfected 
targets  were  added to  each  well and plates were briefly spun at 
1,500 rpm and incubated for 6 h  at 37°C in a SlCr release assay. 
One  lytic  unit  was  determined  by  estimatmg  the  number  of 
lymph node effectors required to cause 10% 51Cr release by fitting 
a  curve to  the data using the equation described by Clark et al. 
(39)  and a program generously supplied by D.A. Clark (McMas- 
ter University, Hamilton, ON). 
Statistics.  Frequency estimates of CTLp were calculated using 
X  2 analysis as described by Taswell (40), by using a computer pro- 
gram kindly provided by Richard Miller (University of Michigan, 
Ann Arbor). Estimates of CTLp frequencies were considered valid 
only if the plot of the logarithm of the fraction of negative cultures 
against the number ofresponder cells on a linear scale obeyed sin- 
gle-order kinetics with a probability greater than 0.05 (41). 
The lytic activity for each mouse is expressed as the mean LU/ 
10  v cells  +  SEM.  Statistical analysis of LU was carried out using 
analysis of variance (ANOVA) based on the error associated with 
the line fitted to the lytic values of at least three effector to target 
dilutions of a given sample. 
Results 
Dissipation of Splenic CTL Memory After lntranasal AdgB8 
Immunization.  The  maintenance of systemic  anti-HSV-2 
CTL was examined m  C57BL/6  mice after i.n. or i.p. im- 
munization with AdgB8 at various time points over a  19-wk 
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Figure 1.  Maintenance  of systemic CTL specific for HSV-2 m mice 
lmmumzed 1  p. (A) but not l.n. (B) with AdgB8. Three mice were immu- 
razed at each time point over the com~e of 19 wk at ~5 wk intervals.  As a 
control group three rmce were l.n. lmmumzed at 9 wk with AdE3- (B). 
After 6 d of in vitro culture with irradiated, AdgB8-mfected stimulator cells 
the pooled  splenocytes in each group  were  examined for CTL acnvlty 
against HSV-2-mfected  MC57 targets. Effector to target ratios reported 
are 40:1 (11), 2(1:1 ([]), 10:1 ([~), and 40'1  +  antl-CD3 (D). 
period (Fig.  1). To determine whether memory CTL were 
present within the systemic immune  system,  HSVgB-spe- 
cific  splenocytes  were  first  expanded  in  vitro  after  bulk 
stimulation  with  antigen.  The  expansion  of the  memory 
population permits  qualitative  evaluation of the  extent  of 
CTL memory in the spleen. Both  i.p.  and i.n. AdgB8 im- 
munization resulted in the  presence  of splenic  effectors  at 
early  time  points  post  immunization as  evidenced by  the 
high  levels  of  CTL-mediated  killing  of  HSV-2-infected 
syngeneic targets  (Fig.  1,  A  and B).  The  lysis was  T  cell- 
mediated  since  anti-CD3  treatment  markedly  inhibited 
killing (Fig.  1, A  and B).  Further,  CTL-mediated lysis was 
MHC-restricted and virus-specific because uninfected syn- 
geneic and allogeneic HSV-infected targets were not killed 
(data not shown).  In mice immunized i.p. with AdgB8 the 
level  of lysis  of  HSV-2-infected  targets  was  maintained 
over the  19-wk  period  (Fig.  1 A).  In contrast,  in i.n. im- 
munized mice the lysis of HSV-2-infected targets decreased 
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Mice were lrnmunized 1  n  or 1.p. and 7 mo later challenged l.n  with 
HSV-2. The spleens and MLN were xsolated 3 d later and combined 
within groups The spleens (/3) were sumulated tbr 6 d with irradiated 
AdgB8-infected stimulators before being analyzed in a CTL assay. The 
MLNs (A) were cultured without antigen stimulation  for 3 d before being 
assayed CTL acuvity  is reported at E/T ratios of 40 1 (11), 20:1 (~), 10:1 
([~), and 40 1 + anti-CD3 (D). 
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Figure  3.  Long-term  CTL memory in the respiratory-associated  lym- 
phoid tissue of mice immunized 1.n. with AdgBS. Two mice immunized 
either i n. or in the h f.p  with AdgB8 were I.n. challenged 19 mo later 
with HSV-2. A naive (unlmmumzed) mouse was also challenged and 
served as a control representing  the magmitude  of a primary response. 2 d 
after Ln. challenge the MLN were cultured without anugen stmmlatlon 
for 3 d before being examined for CTL activity. MC57 targets were in- 
fected wath HSV-2 and the 40'1 ([~) and 40.l  + anti-CD3 (IS]) E/T ra- 
tios are reported as well as the lytlc  activity  (I) m mean LU per  1()  7 
mononuclear cells + SEM  * Significantly  different  from nawe and h.f.p. 
mmmmzed mice (P <0.0001). 
to levels similar to that of control mice over the  19-wk pe- 
riod (Fig. 1 B).  Moreover, in separate experiments, splemc 
CTL precursor frequencies were  estimated at  1 in 21,280 
(95% confidence interval (CI),  12,658 to 35,714) and 1 in 
500,000 (95% CI, 250,000 to 106) mononuclear cells  14 mo 
post  i.p.  or  i.n.  immunization, respectively.  In  addition, 
hmiting  dilution  analysis  using  fibroblasts  infected  with 
AdgB8 as stimulators gave similar results (data not shown). 
These results indicate that while both routes of AdgB8 im- 
munization initially resulted in the  presence  of anti-HSV 
CTL in the spleen, only i.p.  immunized mice maintained 
long-term splemc anti-HSV memory CTL. 
CTL Memory Responses in the Draining Lymph Nodes of the 
Respiratory Tract  After AdgB8 Immunization and bmanasal HS V-2 
Challenge.  To  investigate antigen-specific CTL  memory 
within the respiratory tract, we examined the levels of CTL 
activity in the draining lymph nodes after an HSV-2 chal- 
lenge. We first determined that primary anti-HSV CTL re- 
sponses  in  the  draining lymph  nodes  of HSV-2-infected 
mucosal  tissues  of naive mice  appeared  at  low  levels  on 
days  2-3  and  peaked  by  day  5  post  infection  (data  not 
shown). Therefore, in assessing memory CTL responses in 
the respiratory tract of AdgB8 immunized mice, mice im- 
munized 7 mo previously with AdgB8 were challenged i.n. 
with  HSV-2,  and  3  d  later  the  mediastinal lymph nodes 
(MLN) which dram the respiratory tract were examined for 
CTL activity. Fig. 2 A  shows that only lymphocytes from 
the MLNs  of mice immunized i.n. 7  mo previously wtth 
AdgB8  contained  a  strong  anu-HSV-2  CTL  recall  re- 
sponse. In contrast, MLN cells from i.p. AdgB8 immunized 
mice failed to appreciably lyse HSV-2-1nfected targets (Fig. 
2  A).  This indicates that long-term CTL memory, as  ob- 
served through a functional recall response, existed within 
the local mucosal immune compartment of the respiratory 
tract after i.n. but not i.p.  AdgB8 immunization. Interest- 
ingly, when the spleens of these same mice were examined 
for  antl-HSV  CTL,  only  mice  immunized i.p.  demon- 
st-rated splenocytes that recognized and killed HSV-2-infected 
targets (Fig. 2 B). 
To further investigate the maintenance of long-term T  cell 
memory in the  respiratory tract,  we  examined individual 
mice immunized with AdgB8 and compared them to un- 
immunized (naive) animals 2 d  after i.n. HSV-2 challenge. 
Fig. 3  demonstrates that at 2  d  post i.n. HSV-2 challenge, 
only MLN  lymphocytes from  the  mouse immunized i.n. 
with AdgB8  19 mo previously demonstrated the ability to 
lyse  HSV-2-infected  syngeneic  targets.  In  contrast,  the 
lymphocytes from the MLN of the naive or h.f.p,  immu- 
nized mouse failed to appreciably lyse HSV-2-infected tar- 
gets  (Fig.  3).  Furthermore, when the  lyric activity in the 
MLNs of the three mice were examined, the lymphocytes 
in  the  i.n.  AdgB8  immunized mouse  contained  signifi- 
cantly (P ~0.0001) and more than eight umes the lyric ac- 
tivity than that found in either the naive or i.p. immunized 
mouse  (Fig.  3).  These results are  representative of several 
experiments in which  individual mice  were  examined at 
late time points post immunization and at no time did we 
observe killing from the MLNs ofi.p, or h.f.p, immunized 
mice. HSV-2-specific lysis was T  cell-mediated since it was 
completely  inhibited  with  anti-CD3  antibody  (Fig.  3). 
Killing was  also  virus-specific and MHC-restricted in the 
i.n. immunized mouse because uninfected and allo-infected 
targets were not lysed (data not shown). Figs. 2 and 3 dem- 
onstrate  that  long-term T  cell memory responses,  as  ob- 
served in the draining lymph nodes, are maintained in the 
respiratory tract following local (i.n.) but not systemic im- 
munization. 
In Fig. 4 the presence of short-term CTL memory in the 
respiratory  tract  after  i.n.  or  h.f.p.  AdgB8  immunization 
was evaluated. 3  wk post immunization both these groups 
demonstrated a  CTL recall response that was  greater than 
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Figure  4.  Short-term CTL  memory in the respiratory-associated lym- 
phoid nssue of mice immunized systemacally or mucosally with AdgB8. 
Two nuce immunized other Ln.  or in the h f.p. with AdgB8 were  Ln. 
challenged 3 wk later with HSV-2. Nmve (ummmunized) rmce were also 
challenged and served as controls representing the magmtude ofa pnmary 
response. 2 d after 1.n. challenge the MLN were isolated and incubated for 
3 d without antigen stlmulatmn before being exarmned for CTL activity. 
MC57 targets were infected with HSV-2 (A) or VacgB11 (/3) and the 40:1 
([~)  and 40:1  +  ann-CD3 (El) E/T ratios are reported as well as the lyric 
acnwty (11) m  mean LU per  107  mononuclear cells  +  SEM  * Slgnlfi- 
candy different from the naive mouse (P <0 0001). 
that  of the  naive  mouse  and  was  completely  inhibitable 
with anti-CD3  (Fig. 4 A). As well,  the lytic activity in the 
MLNs  of i.n.  or h.f.p,  immunized  mice  was  significantly 
greater than in the naive mouse (P ~<0.0001).  In fact, there 
was  more  than  eight  and  four  times  the  number  of lytic 
units  in i.n.  or h.f.p,  immunized  mice,  respectively,  dem- 
onstrating  that  shortly  after  either  mucosal  or  systemic 
AdgB8 immunization mice were able to mount antl-HSV-2 
CTL  memory  responses  In  the  mucosal-associated  lym- 
phoid tissue of the respiratory tract (Fig. 4 A). 
To determine whether the short-term CTL memory re- 
sponse to HSV-2 challenge was specific for gB of HSV, tar- 
gets were  infected with  a  vaccinia virus  vector expressing 
gB of HSV (VacgB 11). The lysis of  VacgB 11-infected targets 
was  similar  to  that  of HSV-2-infected  targets  (Fig.  4  B), 
confirming  the  presence  of short-term  CTL  memory  re- 
sponses in both i.n. and h.f.p, immunized mice. Moreover, 
since  the  lysis  and  lyric  activity  against  VacgB11  infected 
targets  was  as  high  as  against  HSV-2-infected  targets,  the 
CTL  memory  response  to  HSV-2  challenge  was  for  the 
most part directed against gB of HSV (Fig. 4  B). 
CTL Memory Responses in the Draining Lymph Nodes of the 
Genital  Tract After  AdgB8  Immunization  and  Intravaginal 
Challenge with HSV-2.  We next addressed the question of 
whether the maintenance  of CTL memory in mucosal tis- 
sues was purely  a local phenomena  (i.e.,  due  to local im- 
munization)  or  was  also  present  at  distant  mucosal  sites. 
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Moreover, since HSV-2 is a sexually transmitted  virus and 
since  one of our main interests  has been the development 
and  characterization  of anti-HSV-2  immune  responses  in 
the genital tract, we investigated CTL memory responses at 
this  site  after AdgB8 immunization.  Fig.  5  consists of two 
representative  experiments  showing  CTL  recall  responses 
in  individual  mice at  early  (5-9  wk)  and late  (15-18  mo) 
time points post immunization (Fig. 5, A  and/3).  The mag- 
nitude  of the primary response is indicated by the CTL ac- 
tivity  in  the  naive  (unimmunized)  mice.  In these  experi- 
ments,  lymphocytes  were  isolated  from  the  iliac  lymph 
nodes  (ILN),  which  drain  the  genital  tract,  3  d  after  ivag 
HSV-2  challenge  and  examined  for  their  ability  to  lyse 
HSV-2-infected targets.  Fig. 5 A  demonstrates that at early 
time  points  post  immunization  (i.e.,  5  wk)  both  i.n.  and 
i.p.  AdgB8  immunized  mice  demonstrated  lysis  of HSV- 
2-infected  targets  that  exceeded  primary  responses  ob- 
served in naive mice. The killing was TCR-mediated as in- 
dicated by the inhibition  of lysis  with  anti-CD3  antibody. 
The lytic  activity in both  groups was not only similar but 
was  significantly  (P  ~<0.0001)  and  more  than  11  times 
greater than that observed in the naive mouse. Thus, as ob- 
served  in  the  respiratory  tract,  shortly  after  immunization 
there  exists  a  phase  of CTL  memory  in  the  genital  tract 
which is not dependent  on the route  of immunization.  In 
the  second experiment  (Fig.  5  /3)  mice  were  examined  9 
wk  post  immunization  and  again  ILN lymphocytes from 
the  mouse  immunized  i.n.  maintained  short-term  CTL 
memory.  However,  at this  time  point the  i.p.  immunized 
mouse lacked a significant memory response when the lysis 
of targets  or  the  lytlc  activity  was  compared  to  that  ob- 
served in  the  naive  mouse  (Fig.  5  B).  Therefore,  systemic 
immunization  induced  a  phase  of short-term  memory  in 
the genital tract, which we observed in the draining lymph 
nodes and which was absent by 9 wk post immunization. 
To  examine  the  long-term  maintenance  of  mucosal 
CTL  memory,  mice  were  challenged  with  HSV-2  intra- 
vaginally 15 or 18 mo after AdgB8 immunization (Fig. 5, A 
and  /3). At  18  and  15  mo,  i.n.  immunized  mice  demon- 
strated  much higher as well as anti-CD3  inhibitable  levels 
of killing when compared to i.p.  immunized mice. Indeed, 
the  level  of lysis  and  the  lyric  activity  in  i.n.  immunized 
mice at 18 or 15 mo post immunization was at least as high 
as that occurring at 5  or 9  wk post i.n.  immunization,  re- 
spectively (Fig.  5, A  and B).  Furthermore,  in both experi- 
ments the lytic activity in ILN cells ofi.n, immunized mice 
was  significantly  (P  ~<0.0001)  and  more  than  four  times 
greater than that observed in i.p.  immunized mice. In con- 
trast, mice immunized i.p.  18 or 15 mo before lvag HSV-2 
challenge lacked a memory response and their lytic activity 
was not significantly different from that of the naive mice 
(Fig.  5, A  and B).  These results indicate  that only i.n.  im- 
munized mice maintained long-term anti-HSV CTL mem- 
ory responses in the genital tract  and the  strength  of these 
responses did not appear to decrease with time. 
Splenic CTL Responses in AdgB8 Immunized Mice After In- 
travaginal HSV-2 Challenge.  The  maintenance  of splenic 
CTL  memory  in  AdgB8  immunized  and  lvag challenged Route  Time 
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mice  in Fig.  5  B  was  examined  (Fig.  5  C).  3  d  after  ivag 
HSV-2  challenge,  the  splenocytes  from  mace  immunized 
i.p.  with  AdgB8  (9  wk  and  15  mo  previously)  demon- 
strated anti-HSV-2 CTL activity (after in vitro stimulation) 
(Fig.  5  C).  This is in agreement with  our previous results 
(Fig.  1 A) which demonstrated that i.p. AdgB8 immuniza- 
tion  induced  long-term  splenic  CTL  memory.  Interest- 
ingly, neither of these  mice demonstrated a  CTL memory 
response in their ILNs after ivag HSV-2 challenge (Fig. 5  B). 
In contrast, both mice immunized i.n. (i.e., 9 wk or 15 mo 
previously) mounted CTL memory responses in their ILNs 
(Fig.  5  B)  yet  failed to  display high  levels  of ann-HSV-2 
CTL in their spleens (Fig. 5  C).  In fact,  the mouse immu- 
nized i.n. 15 mo previously displayed a level of killing from 
the spleen similar to the naive mouse. These results suggest 
that immunological T  cell memory can be observed func- 
tionally in mucosal  tissues  without  being observed  in  the 
systemic system and vice-versa. 
Specificity  of the  CTL  Memory  Responses  in  the  Draining 
Lymph Nodes  of the  Genital  Tract After AdgB8 Immunization 
and IntravaginaI Challenge with HSV-2.  To  examine the  spe- 
cificity and further characterize  the long-term memory re- 
sponse  m  the  genital  tracts  of i.n.  immunized  mice,  the 
anti-HSV CTL activity in ILNs from mice immunized 5 mo 
previously were  examined 2  d  post HSV-2 challenge using 
targets  infected  with  VacgB11  (Fig.  6).  In  addition,  two 
systemic routes  of immunization (i.p.  and h.f.p.)  were  as- 
sessed and a naive mouse was included to represent the pri- 
mary response to gB of HSV. Fig. 6 demonstrates that 2 d  af- 
ter ivag HSV-2 challenge the ILN cells in the i.n. imrnumzed 
mouse lysed the VacgBll  infected targets and this lysis was 
completely  inhibitable with  anti-CD3  antibody.  Further- 
more,  the  lyric  activity in the  1.n.  immunized mouse  was 
significantly (P ~<0.0005)  and more than four times greater 
than in the naive or systemically immunized mice.  In con- 
trast,  the level of lysis of VacgB11  targets an naive and sys- 
temically immunized mice  were  very low  and not always 
inhibitable with ann-CD3. The lyric activity was  also very 
low  and not significantly different between the  naive and 
systemically immunized mice  (Fig.  6).  These  results  con- 
firm that long-term immunological T  cell memory is main- 
tained in the genital tracts of mice immunized i.n., but not 
Figure  5.  Short- and long-term CTL memory in the genital-associated 
lymphmd tissues (A and B) and spleens (C) of AdgB8 immunized mace. 
Individual mace in two separate experiments (A and /3) were 1.n. or 1  p 
immunized with AdgB8. At 5 wk and 18 mo (A) or 9 wk and 15 mo (B) 
post lmnlunlzatlon  mice were challenged 1rag with HSV-2  3 d later the 
ILN (A and B)  draining the genital tract were  isolated from individual 
nuce, cultured  for 3  d  without antigen  stimulation,  and examined  for 
CTL activity against HSV-2-1nfected MC57 targets at E/T ratios of 40.1 
([~) and 40:1 +  antl-CD3 (IS]) (A and/3). In addition, the lyttc activity 
(11) was determined  and expressed m mean lytic units per 107 mononu- 
clear cells -+ SEM. * Significantly different from the naive and 18 mo I p 
lmmumzed mouse (P <0.0001)  (A) and from the naive and l.p. umnu- 
nlzed mice at 9 wk and 15 mo (P <0 0001) (B). C shows the CTL acnv- 
ity against HSV-2-infected targets from the spleens of mice in B  Spleno- 
cytes were  stimulated  as  described in the  Materials and  Methods  and 
incubated with targets at E/T ranos of 40 1 (I), 20:1 ([]), 10.1 ([~), 41)'1 + 
anti-CD3 (7]). 
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Figure 6.  Specxficlty of long-term memory CTL in the genltal-assoo- 
ated lymphoid tissue of intranasally immunized mice. Mice immunized 
5 mo previously with AdgB8 by the 1 n., l.p., or h.fp. routes were chal- 
lenged wag with HSV-2. A naive  (unimmunlzed)  mouse  was also chal- 
lenged and served as a control representing  the magnitude  of a primary 
response. 2 d later the ILNs were isolated from mdlvMual mxce, incubated 
for  3  d  without  antigen  snmulatmn,  and  examined  for  CTL  activity 
against VacgBll-mfected targets. The 40:1 (~),  and  40:1  +  antl-CD3 
systemically,  with  AdgB8  and  demonstrates  that  these 
memory CTL  are specific for gB of HSV. 
Limiting Dilution Analysis of CTLp Frequencies in Mice One 
Year AfierAdgB8 bnmunization.  To  further  examine  the 
compartmentalization  of memory  CTL  in  AdgB8  immu- 
nized  mice,  we  determined  the  precursor  frequencies  of 
gB-specific CTL  in the ILNs of mice immunized  1 yr pre- 
viously  and  60  h  after  an  intravaginal  HSV-2  challenge 
(Table  1).  Unlike splenic memory CTL which typically re- 
quire antigen to expand into effectors, gB-specific CTLp in 
the  draining  lymph  nodes  of HSV-2-infected  tissues  were 
activated  in  vivo  and  therefore,  functional  analysis  of the 
CTLp frequency is possible after expansion ofeffectors in the 
absence of antigen.  Analysis of the frequencies of gB-specific 
CTLp  expanded under limiting dilution conditions showed 
that  the  ILNs  of i.n.  immunized  mice  (rangang  from  1  in 
3411-5946)  contained  significantly  and  several-fold  more 
gB-specific CTLp  than the ILNs of control (unimmunized; 
ranging  from  1  in  23899-35350)  or  systemically  (i.p.  or 
h.f.p.;  ranging  from  1  in  15643-31006)  immunized  mice 
(Table  1).  Moreover,  the  CTL  frequencies  demonstrated 
(E]) E/T ratms  are shown  as well as the lytlc activity  (')  expressed m 
mean lync units per 107 nmnonuclear  cells -+ SEM. * Significantly differ- 
ent from the naive, t.p. and h.t2.p, immunized rmce (P <0.0005). 
Table  1.  Cytotoxic T Lymphocyte Memory Responses in the Spleen and Iliac Lymph Nodes of Mice hnmunized One Year Previously 
With AdgB8 
ILN  Spleen 
Route of AdgB8  Reciprocal CTLp 
immumzauon*  frequency (95% CI)*  Probability5 
CTL lysas  Reciprocal CTLp 
at 80:1  (SD)II  frequency (95% CI)  Probabihty 
P  P 
Intranasal  3411  (2645-4924)  0.99  3  (0.6)  667609  (421812-1599898)  0.82 
5946 (4497-8774)  0.41  2  (2.6)  325543  (325543-1006668)  0.52 
Intrapentoneal  23607  (18271-33346)  0.84  52 (1.0)  66265  (51694-92273)  0.99 
30391  (23431-43232)  0.87  50 (3.4)  55068  (43388-75351)  0.54 
31006  (23790-445050  0.76  37 (2.6)  72671  (55262-106092)  0.55 
Hind Foot Pad  23555  (17586-35655)  0.70  75  (6.3)  95959  (67974-163100)  0.19 
15643  (12002-22453)  0.55  72  (6.8)  94844  (70597-144460)  0.72 
Ummmunized  26106  (20118-37169)  0.71  -  - 
23899  (18365-34208)  0.51  -  - 
35350  (26590-52717)  0.99  -  - 
*1 yr after AdgB8 immunization mice were challenged lvag wlth 2  X  10  v PFU of HSV-2 and 60 h later the lymphocytes from the spleens and ILN 
were isolated and the CTLp frequencms  were determined m a limiting dilution assay. ILNs were cultured under expansion  conditions without exog- 
enous antigen. 
¢Reclprocal frequency of culture wells exhibiting posinve cytolync acnvity (three standard  deviations  above the mean values obtained from cultures 
wxthout responders)  were determined by mlmmal X  2 analysis. Each frequency and 95% CI represents  an individual mouse (2-3 per group)  and all an- 
imals were analyzed together in one experiment against VacgB11  infected targets. 
%Probability of obeying single-order klnencs,  based upon X  2 analysis for n-1 degrees of freedom, where n was always greater  than 5 for ILNs and 4 
for splenocytes  and represents  the number of responder cell dilutions  tested. 
biCTL_mediated lysls was determined after bulk stimulation  of splenocytes  as descnbed in the Materials and Methods. 
1885  Galhchan and Rosenthal Table 2.  Cytotoxic T Lymphocyte Memory Responses in the Spleen and Iliac Lymph Nodes qf Mice Recently Immunized with AdgB8 
ILN  Spleen 
Route of AdgB8  Time after  Reciprocal CTLp 
immunization*  immunization  Frequency (95% CI)*  Probabihty  ~; 
Reciprocal CTLp 
frequency (95% CI)  Probability 
P  P 
Intranasal  2 wk  4680 (3510-7000)  0.72  145600  (98510-278900)  0.10 
4030 (3030-5990)  l).44  95020 (64570-179900)  0.21 
6850 (5300-9650)  0.94  86470 (61670-144600)  0.61 
12 wk  2520 (1980-3490)  0.33  127560  (91100-212800)  0.16 
5150 (3860-7760)  0.40  101890  (72000-174100)  0.26 
3590 (2850-4860)  0.88  142150  (100100-245100)  0.52 
Intraperltoneal  2 wk  13820  (10590-19900)  0.60  46130 (32180-81410)  (I.32 
15310  (11530-22790)  0.97  40230 (27600-74170)  0.20 
13140  (10140-18630)  0.74  47900 (32530-90800)  0.64 
12 wk  29290 (22090-43450)  0.64  29050 (19970-53260)  0.17 
17830  (13390-26680)  0.80  49880 (35360-84620)  0.08 
27170 (2092O-38720)  0.84  45590 (31300-83890)  0.05 
*2 or 12 wk after AdgB8 immunization mice were challenged lvag with 2 ×  107 PFU of HSV-2 and 60 h later the lymphocytes from the spleens and 
ILN were isolated and the CTLp frequencies were determined In a limiting dilution assay. ILNs were cultured under expansion conditions without 
exogenous anngen. 
*Reciprocal frequency of culture wells exhihmng positive cytolytic actlvity (three standard dewatlous above the mean values obtained from cultures 
without responders) were deterrmned by minimal X  2  analysis.  Each frequency and 95% CI represents an individual mouse (2-3 per group) and all an- 
imals were analyzed together in one experiment against VacgB 11 infected targets 
~Probability of obeying single-order kinetics, based upon X  2 analysis  for n-1 degrees of freedom, where n was always greater than 5 for ILNs and 4 
for splenocytes and represents the number of responder cell dilutions tested. 
that  the  recall responses  in  systemically immunized  mice 
were  no  different than the primary responses occurring in 
control animals, in&caring that  long-term mucosal  T  cell 
memory is maintained after mucosal but not systemic im- 
munization. 
Analysis of the  splenocytes  of these  same  ammals  ex- 
panded  with  antigen  under  limiting  dilution  conditions 
demonstrated that the precursor frequencies of gB-specific 
CTL in i.n. immunized mice were extremely low (ranging 
from 1 in 325543-667609).  In fact, we were unable to de- 
tect any gB-specific CTL-mediated lysis after bulk stimula- 
tion of splenocytes (Table  11. In contrast, mice immunized 
systemically maintained relatively high frequencies of CTLp 
(ranging from  1 in 55068-95959)  and CTL-mediated lysis 
was readily detectable after bulk stimulation. 
Limiting  Dilution  Analysis  of  CTLp  Frequencies  in  Mice 
Shortly AfierAdgB8 Immunization.  To  evaluate  the  early 
development of mucosal T  cell memory in AdgB8 immu- 
nized  mice,  we  examined  the  CTLp  frequencies  in  the 
ILNs of mice 2  or  12  wk after AdgB8 immunization. The 
results in Table 2  demonstrate that 60 h  after an intravagi- 
nal HSV-2 challenge, the gB-specific CTLp frequencies of 
ILN cells in i.n. immunized mice (ranging from 1 in 2523- 
6845) were significantly higher than in i.p. immunized mice 
(at either time point; ranging from 1 in 13135-29292).  In- 
terestingly, the CTLp frequencies were similar in mace im- 
munized i.n. at 2,  12, or 52 wk previously (ranging from  1 
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in 2523-6845)  (Tables  1 and 2).  Although the gB-speclfiC 
CTLp frequencies in the ILNs ofi.p, immunized mice at 2 wk 
(ranging from 1 in 13135-15311)  were not as high as in i.n. 
immunized mice, they were higher than at 12 wk (ranging 
from  1 in  17833-29292).  Moreover,  by  12  wk the  CTLp 
frequencies in the ILNs ofi.p, immunized mice were simi- 
lar  to  those  observed in  unimmunized  mice  in  Table  1, 
suggesting that systemic immunizanon can provide mucosal 
T  cell recall responses,  however,  the  maintenance  of this 
mucosal T  cell memory is short-lived. 
The  gB-specific  splenic  CTLp  frequencies  were  also 
determined in  these  mice  and  demonstrate  that  both  1.n. 
and i.p. immunization successfully induced short-term lev- 
els of T  cell memory within the systemic immune  system. 
However, the frequencies were generally two- to threefold 
higher  in  1.p.  immunized  mice.  In  addition,  the  splenic 
CTLp frequencies in i.p. immunized mice only slightly de- 
creased from 2 wk (ranging from 1 in 40233-47904)  to 1 yr 
(ranging from  1 in 55068-72671),  whereas,  in i.n.  immu- 
nized mice there was a substantial decrease in CTLp frequen- 
cies during this period (two- to sevenfold) (Tables 1 and 2). 
Discussion 
T  cell memory has been functionally viewed as the more 
rapid generation of recall responses following a second ex- 
posure  to  antigen  (13,  28,  29,  31).  Increased numbers  of 
Tissues antigen-specific T  cell precursors as well as qualitative dif- 
ferences in  memory T  cell  activation requirements  likely 
contribute  to  the  magnitude  of recall  responses  (42-46). 
The ability of memory T  cells to persist for long periods of 
time may depend  on several factors, including  the  persis- 
tence  or  complexity of antigen  (16,  17),  regulatory  net- 
works  (18),  cross-stimulation  (19)  or  long-lived  T  cells 
(13-15).  In  addition,  the  maintenance  of T  cell memory 
may depend  on the  tissues in  which  exposure  to  antigen 
first occurred.  Indeed, the analysis  of surface markers on T 
cells  has  demonstrated  that  the  recirculation  of activated 
and memory lymphocytes is selective and depends on the 
tissues and lymph nodes from which the lymphocytes orig- 
inated  (47).  By using recall responses we have investigated 
CTL memory in mucosal and systemic immune compart- 
ments  after various  routes  of immunization  with  an  ade- 
novirus vector expressing gB of HSV. Our results indicate 
that  CTL memory, when  examined as  a functional  recall 
response, has both an early and a late phase which manifests 
in the biphasic expression of memory CTL within a given 
tissue  depending  on  the  site  of initial  antigen  exposure. 
More  specifically, the  presence  of systemic CTL was ob- 
served to be short-lived after i.n.  immunization,  however, 
mucosally,  CTL  memory  was  long-lived.  Similarly,  sys- 
temic immunization resulted in short-lived mucosal mem- 
ory CTL, but long-lived systemic CTL. In addition, intra- 
nasal  immunization  resulted  not  only in  long-term  CTL 
memory in the local mucosal tissues  of the respiratory tract, 
but also distantly in the mucosal tissues  of the genital tract. 
This would imply that the genital tract is an implicit effec- 
tor  site  within  the  common  mucosal  immune  system. 
Therefore,  our  results  demonstrate  functionally  the  phe- 
nomenon  of selective  recirculation  of memory  lympho- 
cytes to the tissue compartments in which  sensitization  to 
antigen first occurred. In addition, there is a short-lived pe- 
riod in which T  cell memory can be functionally observed 
within  the  opposing immune  compartment (i.e.,  mucosal 
versus systemic). 
Although we have established that AdgB8 immunization 
results  in long-lived CTL, we have not explored the under- 
lying  mechanism  of this  memory.  However,  recent  evi- 
dence (48, 49) suggests that infection with similar replication- 
competent recombinant adenoviruses (E3 inserts)  results in 
only short-term expression of inserted antigen,  suggesting 
that  persistent  antigen  production  is  not  the  underlying 
mechanism responsible for the  long-term maintenance  of 
CTL memory within our system. Indeed, these studies also 
demonstrated that initially, vector derived antigen was present 
in  both systemic and  mucosal immune  compartments re- 
gardless  of the  route  of inoculation  (48,  49).  This would 
suggest  that  the  persistence  of antigen  IS  unlikely  driving 
the compartmentalized maintenance of CTL memory. 
The primary observations that led to this study included 
the early detection of anti-HSV CTL in the spleens of i.n. 
or i.p.  AdgB8  immunized mice, but the absence of long- 
term memory from the spleens  of i.n. immunized mice (24). 
As well, mice immunized i.n. with AdgB8 were protected 
against heterologous intranasal challenge with HSV-2, and 
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this protection lasted longer than in  i.p.  immunized mice 
(24).  Moreover, we recently observed that i.n. AdgB8 im- 
munization  protected  mice  from  an  intravagmal  HSV-2 
challenge,  and  this  protection  was  long-lived and  signifi- 
cantly better than after 1.p. immunization (GaUichan,  W.G., 
and K.L. Rosenthal, manuscript submitted for publication). 
By investigating these phenomena further, we show here that 
1.n. and i.p.  routes of AdgB8 immunization initially  induced 
high anti-gB CTLp frequencies and following bulk stimu- 
lation,  similar levels  of splenic  anti-HSV  CTL.  However, 
several months later, bulk stimulation  of splenocytes dem- 
onstrated  that  mice  immunized i.n.  had barely detectable 
CTL specific for HSV.  Limiting dilution  analysis  of mice 
12-14 mo following i.n. immunization confirmed that the 
CTLp frequencies had decreased and had remained perma- 
nently low or undetectable.  In contrast, i.p. immunization 
resulted in relatively high CTLp frequencies for longer than 
14  mo.  Others have also  shown the persistence of splenic 
CTL  following  systemic  exposure  to  gB  of HSV  (50). 
However,  the  transient  nature  of splenic  CTL  following 
1.n. immunization may be due to the selective migration of 
memory T  cells to mucosal sites within the common mucosal 
immune system (1-3, 11,  12, 20, 23, 47). 
Thus, to address these seemingly conflicting observations 
oflong-hved mucosal protection in the absence of systemic 
CTL, we examined short and long-term CTL memory in 
mucosal tissues by assessing recall responses within mucosal 
associated lymph nodes after local HSV-2 challenge. At less 
than  9  wk after either systemic (i.p.  or h.f.p.)  or mucosal 
(i.n.)  routes  of AdgB8  immunization,  we  observed  rapid 
recall responses in  the  draining  lymph nodes  of the lungs 
and genital tract.  In addition,  CTLp frequencies indicated 
that  mucosal  memory responses  were  present  in  animals 
two wk after either systemic or mucosal immunization. Thus, 
short-term CTL memory in mucosal tissues  is not depen- 
dent  on  the  route  of immunization.  In a  similar manner, 
we  examined  short-term  recall  responses  in  the  systemic 
compartment  and  observed  that  mice  immunized  either 
i.n.  or systemically developed memory responses to  h.f.p. 
HSV-2  challenge  (data  not  shown).  These  results  suggest 
that  functionally  there  exists  within  a  population  of re- 
cently activated lymphocytes, T  cells that are capable of re- 
circulating  indiscriminately  throughout  the  body.  This  is 
interesting  since  recently  activated  lymphocytes  or  blasts 
derived from skin  or mucosal tissues  have been shown to 
preferentially but not exclusively migrate back to the tissues 
in which antigen exposure originally occurred (1-3,  11, 12, 
20,  23,  47).  Our findings may then reflect the persistence 
of a population of recently activated lymphocytes that are 
capable of responding to sites of inflammation. This is quite 
possible in light of work demonstrating the increased pene- 
tration  of memory or activated lymphocytes into  sites  of 
antigen  challenge  (2,  12).  Alternatively, the routes  of im- 
munization used here may not reflect tissue restricted infec- 
tion, resulting in some overlap of immune induction within 
opposing immune  compartments.  However,  our observa- 
tion of distinctively compartmentalized long-term memory 
responses  suggests  that  this  mechanism  is  unlikely  to  ac- count for the observed short-term phase ofT-cell memory. 
Moreover,  it  is  interesting  that  as  for  short-term  CTL 
memory, short-term protection from mucosal HSV-2 chal- 
lenge (24) is not dependent on the route of immunization. 
In  our  initial  evaluation  of long-term  mucosal  CTL 
memory, we examined  recall responses in the  respiratory- 
associated  lymphoid  tissue  and  observed  a  dissociation  of 
memory responses in i.n. and i.p. immunized animals. 7-19 
mo after AdgB8 administration  only mice immunized i.n. 
demonstrated CTL memory responses in the draining me- 
diastinal lymph nodes of the respiratory tract.  Interestingly, 
in the mice immunized 7 mo previously, only i.p. immuni- 
zation  resulted  in  the  presence  of long-term  anti-HSV-2 
CTL in the spleen.  These results suggest that mucosally in- 
duced memory lymphocytes are not maintained within the 
spleen but perhaps within  the lymphoid or extralymphoid 
tissues of the respiratory mucosa. 
Our results,  as well as our previous observations of IgA 
induction in the respiratory tract (24), suggest that i.n.  im- 
munization  with  AdgB8  stimulates  the  induction  of im- 
mune responses in the bronchus-associated lymphoid tissue 
(BALT) (51). The BALT serves as part of the mucosa-asso- 
ciated lymphoid tissues (MALT) and as such shares organi- 
zational as well as functional similarities with other mucosal 
surfaces  as  part  of the  common mucosal immune  system. 
Lymphocytes derived from one mucosal tissue can recircu- 
late  through and localize selectively within  other mucosal 
surfaces, including the respiratory tract and uterus (1-3, 52).  In 
agreement  with  this,  we  recently  demonstrated  that  i.n. 
AdgB8 immunization  results  in  the  presence  of secretory 
anti-HSVgB  IgA in  the  genital  tract  (53)  and  protection 
from lntravagmal HSV-2 challenge (54). 
To  investigate  the  extent  of mucosal  CTL memory in 
distant  mucosal tissues  after i.n.  AdgB8 immunization  we 
evaluated  long-term  recall  responses  in  the  genital  tract. 
Our  results  demonstrate  that  mice  immunized  i.n.  with 
AdgB8 and challenged ivag up to 18 mo later with heterol- 
ogous HSV-2 developed strong anti-HSV-2 CTL memory 
responses. Furthermore, limiting dilution analysis of the re- 
call responses  confirmed that i.n.  but not systemically im- 
munized animals  maintained  memory CTL for as  long as 
one  year  either  within  the  genital  tract  or  its  associated 
lymphoid tissues or capable of entering these sites  after in- 
fection. To our knowledge, this is the first functional dem- 
onstration  of long-lived CTL in local and  distant  mucosal 
tissues despite low or undetectable levels of systemic CTL. 
Interestingly,  the  population  of HSV-specific  CTL that 
are  maintained  within  the  systemic  immune  system  after 
i.p. immunization with AdgB8 are unable to mount mem- 
ory responses  to  i.n.  or ivag infection  with  HSV-2.  This 
suggests that the population oflymphocytes present shortly 
after systemic immunization that contained T  cells  capable 
of mounting short-term  mucosal  memory responses  were 
no longer present.  This leaves us to suggest that dunng the 
early stages of an immune response there are populations of 
functionally active T  cells that have no tissue-specific horn- 
ing pattern  or are able to respond or enter sites  of inflam- 
mation and that either do not represent the long-term pop- 
ulation  of memory T  cells  or phenotypically change  into 
that population. 
Our results also demonstrate that the memory responses 
were predominantly specific for gB of HSV since the lytic 
activities and the lysis of targets infected with recombinant 
vaccinia  virus  expressing  gB  of HSV  (VacgB11)  were  at 
least as high as for HSV-2-infected targets. Moreover, anal- 
ysis of CTLp frequencies specific for gB of HSV occurring 
in the recall response demonstrated that the memory CTL 
were in fact predominantly gB-specific. Cytotoxic T  lym- 
phocyte frequencies were also assessed  against HSV-infected 
targets  and the  results  confirmed that i.n.  but not i.p.  im- 
munization induced long-term mucosal CTL memory but 
the absence of long-term splenic  CTL memory. These re- 
sults demonstrate that part of the primary CTL response to 
AdgB8  immunization  and  the  recall  response  to  HSV-2 
challenge are directed towards gB of HSV.  This is in con- 
trast  to  recent  reports  by Nugent  et  al.  (31,  33)  where  it 
was shown that although a large portion of the primary re- 
sponse  to  HSV-1  inoculation  involves  gB-specific  CTL, 
early  secondary  responses  did  not.  Unlike  in  our  system, 
the  lack  of an  early  gB-specific  recall  response  in  their 
model is most likely due  to the fact that HSV-1  was used 
for both sensitization  and  challenge  and likely reflects  the 
interactions  and  complexities  of  numerous  neutralizing 
anti-HSV and CTL epitopes during both periods. 
Currently,  many  vaccines  or  immunotherapeutics  are 
given systemically with the objective of providing mucosal 
immune  functions.  Our studies  demonstrate  that  mucosal 
(i.n.)  administration  of recombinant adenovirus vectors in- 
duced long-lived antigen-specific  CTL an mucosal-associ- 
ated  lymphoid tissues,  whereas  systemic  administration  of 
this  vaccine induced  long-lived CTL systemically but  not 
mucosally. Development of successful vaccines against mu- 
cosal pathogens,  such as  HSV and HIV, will require  the 
induction  of long-lived  mucosal  immune  responses.  Re- 
cently, we showed that intranasal immunization with AdgB8 
induced secretory IgA specific for gB of HSV in both the 
respiratory  (24)  and  genital  tracts  (53).  The  ability  of re- 
combinant  adenoviruses  to  induce  specific  mucosal  hu- 
moral  responses  and  the  long-term  maintenance  of anti- 
HSV-2  CTL in respiratory  and  genital tissues  suggest that 
these vectors may serve as excellent mucosal vaccines. 
Our  results  also  show  that  short-term  mucosal  CTL 
memory was present after both 1.n.  and systemic immuni- 
zation and only after several months did the memory CTL 
responses compartmentalize to mucosal or systemic tissues. 
These  results  have  important  implications  with  regard  to 
the evaluation of vaccines since the time of assessment after 
vaccination may affect detection of CTL activity. Further- 
more,  the  functional  evaluation  of memory CTL  specific 
for  mucosal  pathogens  should  be  based  on  assessment  of 
CTL in mucosal-assocxated lymphoid tissues and not in the 
spleen. 
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